QuantLogix ← HCA scorecard
📅 HCA Earnings Preview
HCA Healthcare, Inc.
Next report (est.)
01/04/2027
Countdown
114 days
EPS growth YoY
+18.1%
Revenue growth YoY
+10.4%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
07/28/2026 ±2.8% +7.3% under-priced
04/29/2026 ±5.1% +0.7% over-priced
10/30/2025 ±4.1% -0.3% over-priced
05/01/2025 ±3.9% -0.6% over-priced
10/31/2024 ±4.5% -0.6% over-priced
07/29/2024 ±3.3% +1.1% over-priced
05/02/2024 ±3.0% -0.2% over-priced
10/26/2023 ±4.1% -1.6% over-priced
Across these reports, options implied an average ±3.9% move vs an actual average of 1.6% — the stock stayed inside the implied band 88% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $7.62 $20.2B $1.9B
Q1 FY2026 $7.15 $19.1B $1.9B
Q3 FY2025 $6.96 $19.2B $1.9B
Q2 FY2025 — $0 $0
Analyst posture
Buy / Strong Buy
17
Hold
12
Sell
1
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 74/100 Full scorecard →
Get alerted before every HCA report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on HCA before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

HCA Healthcare, Inc. (HCA) reports in 114 days, with the next report estimated for 01/04/2027. Across the last 8 reports, options priced an average ±3.9% earnings move while the stock actually moved 1.6% on average — the market has systematically over-priced HCA's earnings risk. Fundamentals into the print: EPS up 18.1% year-over-year, revenue up 10.4%. QuantLogix's live 5-factor engine currently reads HCA as a buy at 74/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →